Behavioral Health Business July 3, 2024
Medication adherence is a critical issue for behavioral health providers. This is especially true for patients with serious mental illness.
More than half of patients with schizophrenia are nonadherent to medication, and 50% of patients with depression and 44% of patients with bipolar disorder are nonadherent to medication, according to a meta-analysis.
In order to help boost medication adherence and help patients improve their condition, many providers are looking to use long-acting injectables. Previous research has connected long-acting injectables to fewer psychiatric hospitalizations, suicide attempts and overall hospitalizations in patients with schizophrenia. Still, operational hurdles and provider comfort with the medications have posed obstacles.
“Long-acting injectables predict much better outcomes. So everything from fewer hospitalizations and fewer ED visits to...
Today's Sponsors
Today's Sponsor